Dose dependent effects of dobutamine on central and regional blood flow in preterm and term neonates

Department of Anaesthesiology and Intensive Care, University of Tartu0 个研究点开始时间: 2016年1月8日最近更新: 2016年4月11日

适应症

试验速览

暂无简介。

•1)Postnatal age below 72 hours
•2)Need for inotropic therapy (based on clinical and biochemical data)
•3)Informed consent given by the parents or guardians
•4)Arterial catheter and/or central venous catheter in place on clinical indication
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 40
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1)Congenital defect that impacts haemodynamics /response to inotropic therapy (congenital heart disease)
•2)Congenital hydrops
•3)Other unresolved cause of low blood flow (air leak)
•4)Known metabolic disease
•5)Informed consent from parents or guardians not obtained
•6)Situation where the treating physician considers a different vasoactive treatment necessary/dobutamine contraindicated
•7)Hypersensitivity to dobutamine or any other component of the study drug

发起方

Department of Anaesthesiology and Intensive Care, University of Tartu